University of Pittsburgh
Pittsburgh, Pennsylvania, 15219, United States
NCT Number: NCT02663778
This randomized clinical trial targets 248 community-dwelling older adults with impaired mobility (i.e. walking slowly; gait speed < 1.20 m/s). The trial compares a 12 week "standard-plus" program of strength, endurance, flexibility plus task specific timing and coordination training to a standard 12 week strength, endurance and flexibility program. The primary outcome is gait speed at 12 weeks. Secondary and tertiary outcomes represent components of the intervention and measures of activity and participation. Delayed and sustained effects of the intervention are examined at 24 and 36 weeks.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Pittsburgh, Pennsylvania, 15219, United States
Walking difficulty is common and costly in older adults. While traditional exercise has been shown to promote physical and mental health and may prevent walking difficulty, such exercise has focused on strength and endurance, and has overlooked a critical component of walking ability; the timing and coordination of movement. Aging and disease alter timing and coordination as reflected by slowed neuromotor performance, increased gait variability and reduced smoothness of movement. Task specific timing and coordination exercise that includes practice of smooth coordinated aspects of gait over multiple walking conditions has the potential to improve walking ability greater than a standard program. Our preliminary data suggest that interventions on timing and coordination of gait impact mobility greater than the standard strength and endurance program. The next key step and the objective of this proposal is to combine the two interventions to determine if potential gains in mobility, activity and participation obtained from a standard plus timing and coordination program, are larger than the gains obtained from the standard program alone. Therefore, the primary aim of the proposed project is to evaluate the impact of adding timing and coordination training to standard strength and endurance training on mobility. Secondary aims include examining 1) additional outcomes representing the components of the intervention and measures of activity and participation, 2) the delayed and sustained effects of the intervention, and 3) the effects of the intervention within various other subgroups of interest. This randomized clinical trial in 248 community-dwelling older adults who walk slowly (i.e. < 1.20 m/s) will compare a standard 12 week strength, endurance and flexibility program to a 12 week "standard-plus" program of strength, endurance, flexibility plus task specific timing and coordination training. The primary outcome is gait speed at 12 weeks. We will also examine secondary and tertiary outcomes representing components of the intervention and measures of activity and participation and the delayed and sustained effects at 24 and 36 weeks. The findings from this efficacy trial will provide evidence for the added value of task specific timing and coordination training for promoting walking ability in older adults and will form the basis for future effectiveness trials. Future work includes translation to nonprofessional exercise leaders with the long-term goal to incorporate neurological training into standard exercise programs for health promotion for older adults.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
weight lifting to increase muscle strength
treadmill walking to increase endurance
stretches to improve flexibility
stepping and walking patterns to improve timing and coordination of gait
Intervention to encourage participants to be more physically active
Time frame: 12 weeks
Usual walking speed over a short distance. A physiologic measure recorded in m/s.
Time frame: 12, 24, and 36 weeks
acceleration signal of usual walking. physiologic measure of the acceleration of walking.
Time frame: 12, 24, 36 weeks
fluctuations in gait characteristics from step to step. physiologic measure of the spatial and temporal gait characteristics
Time frame: 12, 24, and 36 weeks
Self report measure of function
Time frame: 12, 24, and 36 weeks
Self report measure of disability
Time frame: 12, 24, and 36 weeks
physiologic measure of leg strength
Time frame: 12, 24, and 36 weeks
physiologic measure of leg muscle power
Time frame: 12, 24, and 36 weeks
physiologic measure of walking endurance
Time frame: 12, 24, and 36 weeks
physiologic measure of flexibility
Time frame: 12, 24, and 36 weeks
Physiologic measure of physical activity measured using an accelerometer.
Time frame: 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
Self reported falls collected monthly by telephone
Time frame: 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
Self reported emergency room visits collected monthly by telephone
Time frame: 16, 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, and 60 weeks
Self reported hospital admission collected monthly by telephone
University of Pittsburgh
Other
Task Specific Timing and Coordination Exercise to Improve Mobility in Older Adults
Acronym: PRIMA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06008431
Fall, Gait Disorders, Neurologic
Boston, Massachusetts, United States
View Trial DetailsNCT03906032
Femoral Fractures, Fractures, Bone
Waterford, Ireland
View Trial DetailsNCT03479541
Balance; Distorted, Brain Concussion
Portland, Oregon, United States
View Trial DetailsNCT06994741
Amputation, Gait Disorders, Neurologic
Valenton, Val-de-Marne, France
View Trial Details